LAVA Therapeutics NV Cash Flow Quality Index

Latest as of September 2022: -14.59x

LAVA Therapeutics NV cash flow quality index. LAVA Therapeutics NV (LVTX) has a Cash Flow Quality Index of -14.59x as of September 2022. Operating cash flow of $-14.34 Million is below net income of $983.00K, suggesting accrual-heavy earnings not yet converted to cash. See LAVA Therapeutics NV leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-14.59x

Operating CF / Net Income

Operating Cash Flow

$-14.34 Million

USD

Net Income

$983.00K

USD

Data as of

Sep 2022

Most recent filing

LAVA Therapeutics NV Cash Flow Quality Index by Year (None–None)

LAVA Therapeutics NV cash flow quality index by year from None to None. Year-by-year earnings quality comparison for LAVA Therapeutics NV. For the full cash flow conversion analysis, see cash efficiency ratio of LAVA Therapeutics NV.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.